Stocks to Watch on September 30 –
Green Zone
- Reliance Industries: Gets approval from the Ministry of Information and Broadcasting for transferring its non-news business to Star India.
- Adani Enterprises: Its joint venture unit April Moon Retail acquires a 74% stake in Cococart Ventures for ₹200 crore.
- IndusInd Bank: Board proposes a 3-year term for Sumant Kathpalia as CEO, pending RBI approval.
- BEL (Bharat Electronics Ltd): Registers a joint venture with AIA, Israel, for repair and maintenance of medium-range surface-to-air missiles.
- RailTel: Secures an order worth ₹134.5 crore from Adani Connex for advanced smart metering infrastructure.
- Zydus Lifesciences: Gets US FDA approval for Enzalutamide Capsules.
- Welspun Enterprises: Emerges as the lowest bidder for BMC Water Tunnel Project worth ₹1,990 crore.
- Alembic Pharmaceuticals: Receives Establishment Inspection Report (EIR) for its Oral Solid Facility (F-I) from the US FDA.
- Piramal Pharma: US FDA issues an EIR for its manufacturing facility in Ahmedabad.
- Reliance Infrastructure: Calcutta High Court upholds a ₹780 crore arbitration award against Damodar Valley Corporation.
- Hind Rectifiers: Bags an order worth ₹98 crore from Indian Railways.
- Craftsman Automation: Invests ₹126 crore in a German holding company to complete previously announced SPAs and drive growth.
- Kaynes Technology: To acquire a 100% stake in Iskraemeco India for ₹43 crore.
- Mangalore Chemicals: Resumes production at its ammonia and urea plants.
- Asian Energy Services: Secures an ₹82 crore contract from Oil India for 2D seismic data in the Rajasthan Basin.
Red Zone
- GAIL: Revises completion schedule for Srikakulam-Angul and Mumbai-Nagpur pipeline projects.
- Biocon: US FDA issues 4 observations for its API facility in Bengaluru.
- Eicher Motors: Royal Enfield to replace defective reflectors on bikes manufactured between Nov 2022 and March 2023 for free.
- Lupin: Receives 3 US FDA observations each for its Pithampur Unit 1 API and Finished Product Manufacturing Unit.
- Zomato: Akriti Chopra resigns as Co-Founder and Chief People Officer, effective September 27.
- Angel One & 5Paisa: NSE and BSE update transaction charges to comply with SEBI circular.
- Jindal Stainless: Divestment in Jindal Coke and stake acquisition in Iberjindal remain incomplete; options being assessed.
- Sterling & Wilson: Promoters sell a 7.14% stake via block deals; MS Asia and Societe Generale are buyers.
- Jubilant Pharmova: US FDA classifies its Canada unit as “Official Action Indicated”.